Vise Technologies’s Halozyme HALO Stock Holding History

Vise Technologies’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$500K	Hold	7,424	–	–	0.01%	867
2025 Q4	$500K	Buy	+7,424	New	+$499K	0.01%	872

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vise Technologies's HALO Position: Q1 2026 in Review

Vise Technologies held its Halozyme (HALO) position steady in Q1 2026 at 7,424 shares worth $500K. The position accounts for 0.01% of the portfolio, ranked #867.

Vise Technologies first reported a position in HALO in Q4 2025 and has held it in 2 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Vise Technologies held 7,424 shares of Halozyme worth $500K as of Q1 2026.
Vise Technologies left its Halozyme share count unchanged in Q1 2026.
Halozyme made up 0.01% of Vise Technologies's portfolio in Q1 2026, its #867 holding.
Vise Technologies first reported a position in Halozyme in Q4 2025 and has held it in 2 quarters since.
634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.